Early microbiota, antibiotics and health

Cellular and Molecular Life Sciences

Volumn 75, Issue 1, 2018, Pages 83-91

  Nogacka, Alicja M ^a   Salazar, Nuria ^a   Arboleya, Silvia ^b,c   Suárez, Marta ^d   Fernández, Nuria ^d   Solís, Gonzalo ^d   de los Reyes Gavilán, Clara G ^a   Gueimonde, Miguel ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Antibiotics; Infant; Intrapartum antimicrobial prophylaxis; Microbiota

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM; CHLORAMPHENICOL; ERYTHROMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

CESAREAN SECTION; CHILD HEALTH; EVIDENCE BASED MEDICINE; GROUP B STREPTOCOCCAL INFECTION; HEALTH HAZARD; HUMAN; INTESTINE FLORA; INTESTINE FUNCTION; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; MICROBIAL GROWTH; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; MICROFLORA; MOLECULAR INTERACTION; NONHUMAN; OBSTETRIC DELIVERY; PERINATAL PERIOD; PREGNANCY; REVIEW; WELLBEING; BACTERIUM; DRUG EFFECT; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; ORGANISMAL INTERACTION; PHYSIOLOGY; TIME FACTOR;

ANTI-BACTERIAL AGENTS; BACTERIA; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; MICROBIAL INTERACTIONS; TIME FACTORS;

EID: 85030672558     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-017-2670-2     Document Type: Review

References (107)

1. Sekirov I, Russel SL, Antunes CM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904
2. Sommer F, Bäckhed F (2013) The gut microbiota—masters of host development and physiology. Nat Rev Microbiol 11:227–238
3. Kuczynski J, Lauber CL, Walters WA et al (2011) Experimental and analytical tools for studying the human microbiome. Nat Rev Genet 13:47–58
4. Salazar N, Arboleya S, Valdés L et al (2014) The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations. Front Genet 5:406
5. Al-Asmakh M, Zadjali F (2015) Use of germ-free animal models in microbiota-related research. J Microbiol Biotechnol 25:1583–1588
6. Hansen CH, Nielsen DS, Kverka M et al (2012) Patterns of early gut colonization shape future immune responses of the host. PLoS One 7:e34043
7. Renz H, Brandtzaeg P, Hornef M (2012) The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol 12:9–23
8. Olszak T, An D, Zeissig S et al (2012) Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336:489–493
9. Cox LM, Yamanishi S, Sohn J et al (2014) Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158:705–721
10. Gensollen T, Iyer SS, Kasper DL, Blumberg RS (2016) How colonization by microbiota in early life shapes the immune system. Science 352:539–544
11. Claus SP, Tsang TM, Wang Y et al (2008) Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol 4:219
12. Bercik P, Denou E, Collins J et al (2011) The intestinal microbiota affects central levels of brain-derived neurotrophic factors and behaviours in mice. Gastroenterology 141:599–609
13. Clarke G, O’Mahony SM, Dinan TG, Cryan JF (2014) Priming for health: gut microbiota acquired in early life regulates physiology, brain and behavior. Acta Paediatr 103:812–819
14. Neuman H, Debelius JW, Knight R, Koren O (2015) Microbial endocrinology: the interplay between the microbiota and the endocrine system. FEMS Microbiol Rev 39:509–521
15. Jimenez E, Fernandez L, Marin ML et al (2005) Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol 51:270–274
16. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J (2014) The placenta harbors a unique microbiome. Sci Transl Med 6:237ra65
17. Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S (2016) Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep 6:23129
18. Arboleya S, Binetti A, Salazar N et al (2012) Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol Ecol 79:763–772
19. Arboleya S, Sánchez B, Milani C et al (2015) Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics. J Pediatr 166:538–544
20. Dogra S, Sakwinska O, Soh S-E et al (2015) Dynamics of infant gut microbiota are influences by delivery mode and gestational duration and are associated with subsequent adiposity. MBio 6:e02419
21. Dominguez-Bello MG, Costello EK, Contreras M et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107:11971–11975
22. Jakobsson HE, Abrahamsson TR, Jenmalm MC et al (2014) Decreased gut microbiota diversity, delayed Bacteroidetes colonization and reduced Th1 responses in infants delivered by caesarean section. Gut 63:559–566
23. Bäckhed F, Roswall J, Peng Y (2015) Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17:690–703
24. Fouhy F, Ross RP, Fitzgerald GF, Stanton C, Cotter PD (2012) Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes 3:203–220
25. Faa G, Gerosa C, Fanni D, Nemolato S, van Eyken P, Fanos V (2013) Factors influencing the development of a personal tailored microbiota in the neonate, with particular emphasis on antibiotic therapy. J Matern Fetal Neonatal Med 26(S2):35–43
26. Rutten NBMM, Rijkers GT, Meijssen CB et al (2015) Intestinal microbiota composition after antibiotic treatment in early life: the INCA study. BMC Pediatr 15:204
27. Yatsunenko T, Rey FE, Manary MJ et al (2012) Human gut microbiome viewed across age and geography. Nature 486:222–227
28. Arrieta MC, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B (2014) The intestinal microbiome in early life: health and disease. Front Immunol 5:427
29. Fanaro S, Chierici R, Guerrini P, Vigi V (2003) Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 91:48–55
30. Cheng J, Ringel-Kulka T, Heikamp-de Jong I et al (2016) Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children. ISME J 10:1002–1014
31. Hollister EB, Riehle K, Luna RA et al (2015) Structure and function of the healthy preadolescent pediatric gut microbiome. Microbiome 3:36
32. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159:1739–1745
33. Bendtsen KM, Fisker L, Hansen AK, Hansen CH, Nielsen DS (2015) The influence of the young microbiome on inflammatory diseases—lessons from animal studies. Birth Defects Res C Embryo Today 105:278–295
34. Simonyte Sjodin K, Vidman L, Ryden P, West CE (2016) Emerging evidence of the role of gut microbiota in the development of allergic diseases. Curr Opin Allergy Clin Immunol 16:390–395
35. Russell SL, Gold MJ, Hartmann M et al (2012) Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep 13:440–447
36. Russell SL, Gold MJ, Willing BP, Thorson L, Mcnagny KM, Finlay BB (2013) Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes 4:158–164
37. Cho I, Yamanishi S, Cox L et al (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488:621–626
38. Livanos AE, Greiner TU, Vangay P et al (2016) Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nat Microbiol 1:16140
39. Watanabe J, Fujiwara R, Sasajima N, Ito S, Sonoyama K (2010) Administration of antibiotics during infancy promoted the development of atopic dermatitis-like skin lesions in NC/Nga mice. Biosci Biotechnol Biochem 74:358–363
40. Kumar P, Magon N (2012) Hormones in pregnancy. Niger Med J 53:179–183
41. Nuriel-Ohayon M, Neuman H, Koren O (2016) Microbial changes during pregnancy, birth, and infancy. Front Microbiol 7:1031
42. Mueller NT, Whyatt R, Hoepner L et al (2015) Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes 39:665–670
43. Stokholm J, Schjorring S, Eskildsen CE et al (2014) Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin Microbiol Infect 20:629–635
44. Gomez de Agüero M, Ganal-Vonarburg SC, Fuhrer T et al (2016) The maternal microbiota drives early postnatal innate immune development. Science 351(6279):1296–1302
45. Chernikova DA, Koestler DC, Hoen AG et al (2016) Fetal exposures and perinatal influences on the stool microbiota of premature infants. J Matern Fetal Neonatal Med 29:99–105
46. Tormo-Badia N, Hakansson A, Vasudevan K, Molin G, Ahrne S, Cilio CM (2014) Antibiotic treatment of pregnant non-obese diabetic mice leads to altered gut microbiota and intestinal immunological changes in the offspring. Scand J Immunol 80:250–260
47. Munyaka PM, Eissa N, Bernstein CN, Khafipour E, Ghaia JE (2015) Antepartum antibiotic treatment increases offspring susceptibility to experimental colitis: a role of the gut microbiota. PLoS One 10(11):e0142536
48. Khan I, Azhar EI, Abbas AT et al (2016) Metagenomic analysis of antibiotic-induced changes in gut microbiota in a pregnant rat model. Front Pharmacol 7:104
49. Tochitani S, Ikeno T, Ito T, Sakurai A, Yamauchi T, Matsuzaki H (2016) Administration of non-absorbable antibiotics to pregnant mice to perturb the maternal gut microbiota is associated with alterations in offspring behavior. PLoS One 11:e0138293
50. Hu Y, Peng J, Tai N, Hu C, Zhang X, Wong FS (2015) Maternal antibiotic treatment protects offspring from diabetes development in non obese diabetic mice by generation of tolerogenic APCs. J Immunol 195:4176–4184
51. Verani JR, McGee L, Schrag SF (2010) Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B Streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 59(RR-10):1–36
52. Alós Cortés JI, Andreu Domingo A, Arribas Mir L et al (2013) Prevención de la infección perinatal por estreptococo del grupo B. Recomendaciones españolas. Actualización 2012. Documento de consenso SEIMC/SEGO/SEN/SEQ/SEMFYC. Enferm Infecc Microbiol Clin 31:158–172
53. Di Renzo GC, Melin P, Berandi A et al (2015) Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med 28:766–782
54. Benitz WE, Gould JB, Druzin ML (1999) Risk factors for early-onset group B Streptococcal sepsis: estimation of odd ratios by critical literature review. Pediatrics 103:e77
55. Brocklehurst P (2015) Screening for Group B Streptococcus should be routine in pregnancy: ACAINST: current evidence does not support the introduction of microbiological screening for identifying carriers of Group B streptococcus. BJOG Int J Obstet Gynecol 122:368
56. Van Dyke MK, Phares CR, Lynfield R et al (2009) Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 360:2626–2636
57. Ohlson A, Shah VS (2014) Intrapartum antibiotics for known maternal group B Streptococcal colonization. Cochrane Database Syst Rev 10(6):CD007467
58. Bokulich NA, Chung J, Battaglia T et al (2016) Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med 8:343ra382
59. Vangay P, Ward T, Gerber JS, Knights D (2015) Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 17:553–564
60. Azad MB, Konya T, Persaud RR et al (2016) Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG Int J Obstet Gynecol 123:983–993
61. Mazzola G, Murphy K, Ross RP et al (2016) Early gut microbiota perturbations following intrapartum antibiotic prophylaxis to prevent group B Streptococcal disease. PLoS One 11:e0157527
62. Keski-Nisula L, Kyynarainen HR, Karkkainen U, Karhukorpi J, Heinonen S, Pekkanen J (2013) Maternal intrapartum antibiotics and decreased vertical transmission of Lactobacillus to neonates during birth. Acta Paediatr 102:480–485
63. Fouhy F, Guinane CM, Hussey S et al (2012) High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 56:5811–5820
64. WHO/RHR/15.02 (2015) World Health Organization. Statement on Caesarean Section Rates
65. Smaill F, Hofmeyr GJ (2002) Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev 3:CD000933
66. Hill CJ, Lynch DB, Murphy K et al (2017) Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET cohort. Microbiome 5:4
67. Dominguez-Bello MG, De Jesus-Laboy KM, Shen N et al (2015) Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 22(3):250–253
68. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR (2006) Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 117(6):1979–1987. doi:10.1542/peds.2005-1707
69. Stoll BJ, Hansen NI, Bell EF et al (2010) Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network. Pediatrics 126:443–456
70. Goldenberg RL, Hauth JC, Andrews WW (2000) Intrauterine infection and preterm delivery. N Engl J Med 342:1500–1507
71. Stoll BJ, Hansen NI, Sánchez PJ et al (2011) Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 127:817–826
72. Cotten CM, Taylor S, Stoll B et al (2009) Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123:58–66
73. Zhang T, Smith MA, Camp PG, Shajari S, MacLeod SM, Carleton BC (2013) Prescription drug dispensing profiles for one million children: a population-based analysis. Eur J Clin Pharmacol 69:581–588
74. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB (2009) Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77:2367–2375
75. Tanaka S, Kobayashi T, Songjinda P et al (2009) Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol 56:80–87
76. Mathew JL (2004) Effect of maternal antibiotics on breastfeeding infants. Postgrad Med J 80(942):196–200
77. Soto A, Martín V, Jiménez E, Mader I, Rodríguez JM, Fernández L (2014) Lactobacilli and bifidobacteria in human breast milk: influence of antibiotherapy and other host and clinical factors. J Pediatr Gastroenterol Nutr 59:78–88
78. Pacifici G (2006) Placental transfer of antibiotics administered to the mother: a review. Int J Clin Pharmacol Ther 44:57
79. Tamburini S, Shen N, Wu HC, Clemente JC (2016) The microbiome in early life: implications for health outcomes. Nat Med 22:713–722
80. Ong MS, Umetsu DT, Mandl KD (2014) Consequences of antibiotics of antibiotics and infections in infancy: bugs, drugs, and wheezing. Ann Allergy Asthma Immunol 112:441–445
81. Johnson CC, Ownby DR, Alford SH et al (2005) Antibiotic exposure in early infancy and risk for childhood atopy. J Allergy Clin Immunol 115:1218–1224
82. Stensballe LG, Simonsen J, Jensen SM, Bonnelykke K, Bisgaard H (2013) Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr 162:832–838
83. Chu S, Yu H, Chen Y, Chen Q, Wang B, Zhang J (2015) Periconceptional and gestational exposure to antibiotics and childhood asthma. PLOS One 10:e0140443
84. Wickens K, Ignham T, Epton M et al (2008) The association of early life exposure to antibiotics and the development of asthma, eczema and atopy in a birth cohort: confounding or causality? Clin Exp Allergy 38:1318–1324
85. Hill DA, Siracusa MC, Abt MC et al (2012) Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med 18:538–546
86. Gonzalez-Perez G, Hicks AL, Tekieli TM, Radens CM, Williams BL, Lamouse-Smith ES (2016) Maternal antibiotic treatment impacts development of the neonatal intestinal microbiome and antiviral immunity. J Immunol 169:3768–3779
87. Cox LM, Blaser MJ (2014) Antibiotics in early life and obesity. Nat Rev Endocrinol 11:182–190
88. Nobel YR, Cox LM, Kirigin FF et al (2015) Metabolic and metagenomics outcomes from early-life pulsed antibiotic treatment. Nat Commun 6:7486
89. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ (2013) Infant antibiotic exposures and early-life body mass. Int J Obes 37:16–23
90. Bailey LC, Forrest CB, Zhanj P, Richards TM, Livshits A, DeRusso PA (2014) Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr 168:1063–1069
91. Saari A, Virta LJ, Sankilampi U, Dunkel L, Saxen H (2015) Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics 133:617–626
92. Candon S, Perez-Arroyo A, Marquet C et al (2015) Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous model of autoimmune insulin-dependent diabetes. PLOS One 10:e0125448
93. Gibson MK, Crofts TS, Dantas G (2015) Antibiotics and the developing infant gut microbiota and resistome. Curr Opin Microbiol 27:51–56
94. D’Costa VM, McGrann KM, Hughes DW, Wright GD (2006) Sampling the antibiotic resistome. Science 311:374–377
95. Gillings MR (2013) Evolutionary consequences of antibiotic use for the resistome, mobilome and microbial pangenome. Front Microbiol 4:4
96. Toprak E, Veres A, Michel JB, Chait R, Hartl DL, Kishony R (2011) Evolutionary paths to antibiotic resistance under dynamically sustained drug stress. Nat Genet 44:101–105
97. Barbosa TM, Levy SB (2000) The impact of antibiotic use on resistance development and persistence. Drug Resist Updat 3:303–311
98. Versluis D, D’Andrea MM, Garcia JR et al (2015) Mining microbial metatranscriptomes for expression of antibiotic resistance genes under natural conditions. Sci Rep 5:11981
99. Moore AM, Patel S, Forsberg KJ et al (2013) Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes. PLoS One 8(11):e78822
100. Moles L, Gomez M, Jimenez E et al (2015) Preterm infant gut colonization in the neonatal ICU and complete restoration 2 years later. Clin Microbiol Infect 21:936e1–936e10
101. Zhang L, Kinkelaar D, Huang Y, Li YL, Li XJ, Wang HH (2011) Acquired antibiotic resistance: are we born with it? Appl Environ Microbiol 77:7134–7141
102. Gosalbes MJ, Valles Y, Jimenez-Hernandez N et al (2016) High frequencies of antibiotic resistance genes in infants’ meconium and early fecal samples. J Dev Orig Health Dis 7:35–44
103. Fouhy F, Ogilvie LA, Jones BV et al (2014) Identification of aminoglycoside and beta-lactam resistance genes from within an infant gut functional metagenomic library. PLoS One 9:e108016
104. Moore AM, Ahmadi S, Patel S et al (2015) Gut resistome development in healthy twin pairs in the first year of life. Microbiome 3:27
105. Yassour M, Vatanen T, Siljander H et al (2016) Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med 8:343ra81
106. von Wintersdorff CJH, Wolffs PFG, Savelkoul PHM et al (2016) The gut resistome is highly dynamic during the first months of life. Future Microbiol 11:501–510
107. Ravi A, Avershina E, Foley SL et al (2015) The commensal infant gut meta-mobilome as a potential reservoir for persistent multidrug resistance integrons. Sci Rep 5:15317